GeminIQ Website Logo

Viewing ATOS free

Subscribe for full history, 50+ metrics, screener, watchlist...

ATOSSA THERAPEUTICS, INC.

ATOS

Companies in Pharmaceutical Preparations

ATOSSA THERAPEUTICS, INC. (ATOS) — SEC Financial Statements & Analysis

ATOSSA THERAPEUTICS, INC. (ATOS) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
324152586571758084889499
Restricted Cash And Cash Equivalents At Carrying V…
000000000000
Prepaid Expense Current
----------36
Assets Current
Assets Current
3746566369747782879298106
Other Assets Current
----------00
Prepaid Expense And Other Assets Current
2111111122--
Other Assets Noncurrent
122222222221
Equity Securities Without Readily Determinable Fai…
-----0022222
Assets
38485865717679869196102108
Liabilities And Stockhold…
Accounts Payable Current
344211211111
Accrued Liabilities Current
312221222111
Liabilities Current
Liabilities Current
788755665533
Employee Related Liabilities Current
121112111211
Other Liabilities Current
112222122200
Liabilities
788755665533
Preferred Stock Value
0-0000000000
Common Stock Value
222323232232323232323
Stockholders Equity
Stockholders Equity
3039505865717480869198105
Additional Paid In Capital Common Stock
----------255254
Additional Paid In Capital
287286263263262283258257257256--
Treasury Stock Common Value
-1-1-1-1-1-1-1-1-1-1-1-0
Retained Earnings Accumulated Deficit
-256-247-236-227-219-212-205-198-192-186-179-172
Liabilities And Stockholders Equity
38485865717679869196102108
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
0-0000000000
Preferred Stock Shares Outstanding
0-0000000000
Common Stock Par Or Stated Value Per Share
0.180.180.180.180.180.180.180.180.180.180.180.18
Common Stock Shares Authorized
350350350350350350350350350350350350
Common Stock Shares Issued
999991111111
Shares Outstanding
999999888888
Treasury Stock Common Shares
001110111110

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-6.61%-66.43%----------
20251.12%-4.49%-7.87%2.60%31.17%15.58%-1.23%-22.22%-29.63%7.56%-10.52%-54.61%
2024-14.38%-25.34%-16.44%7.26%18.55%14.52%-18.67%-32.67%-44.00%-13.89%34.72%15.28%
202323.94%67.61%49.30%-13.54%-25.00%-27.08%19.05%47.62%34.92%-23.50%-27.00%-43.50%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
4.92
5.53
6.77
9.17
12.67
14.99
13.30
14.35
16.34
17.61
28.35
30.48
Quick Ratio
4.67
5.39
6.70
9.01
12.41
14.76
13.14
14.17
16.04
17.20
27.34
28.82
Working Capital
29.21M
37.36M
47.45M
55.70M
63.32M
69.49M
71.32M
76.02M
81.73M
86.98M
94.20M
102.53M
Leverage & Debt
Debt to Equity
0.24
0.21
0.17
0.12
0.08
0.07
0.08
0.07
0.06
0.06
0.04
0.03
Debt Ratio
0.20
0.17
0.14
0.11
0.08
0.06
0.07
0.07
0.06
0.05
0.03
0.03
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Diluted EPS TTM
-4.37
-4.04
-3.50
-3.33
-3.06
-3.04
-3.21
-3.09
-3.55
-3.58
-3.56
-3.74
Free Cash Flow Per Share TTM
-3.87
-3.46
-3.05
-2.91
-2.59
-2.51
-2.33
-2.23
-2.23
-2.49
-2.37
-2.54
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
42.88%
36.33%
12.15%
10.84%
-11.27%
-15.25%
-9.79%
-18.04%
4.34%
11.62%
22.76%
47.13%
EPS Growth (1Y)
42.88%
32.84%
9.20%
7.89%
-14.03%
-15.10%
-9.77%
-17.46%
5.43%
12.10%
23.57%
47.13%
Valuation Metrics
P/E TTM
-1.20
-2.19
-3.72
-3.73
-3.29
-4.64
-7.10
-5.77
-7.60
-3.69
-3.12
-5.05
P/B
1.49
1.94
2.26
1.86
1.33
1.66
2.59
1.87
2.63
1.22
0.95
1.52
Market Cap
45.35M
76.21M
112.38M
107.21M
86.65M
118.31M
191.17M
149.62M
225.58M
110.95M
93.09M
159.54M
Enterprise Value
13.64M
34.91M
60.53M
49.35M
21.54M
47.22M
116.41M
70.10M
141.62M
22.49M
-944.09K
60.15M
Calculated Values
Free Cash Flow TTM
-33.40M
-29.79M
-26.29M
-25.04M
-22.31M
-21.05M
-19.57M
-18.69M
-18.64M
-20.96M
-19.92M
-21.45M
Net Debt
-31.72M
-41.30M
-51.85M
-57.86M
-65.12M
-71.08M
-74.77M
-79.53M
-83.96M
-88.46M
-94.03M
-99.39M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-05-21Purchase
Owner: Quay, Steven C
Title: President & CEO
Shares: 11,239
Price/Share: $0.88
Value: $9,890.32
Shares Owned: 13,898
Relationship: Director,Officer
Ownership: Direct
2025-03-26Purchase
Owner: Remmel, H. Lawrence
Title: -
Shares: 10,000
Price/Share: $0.70
Value: $7,000.00
Shares Owned: 10,257
Relationship: Director
Ownership: Direct
2024-04-10Purchase
Owner: Finn, Jonathan
Title: -
Shares: 25,000
Price/Share: $1.77
Value: $44,250.00
Shares Owned: 25,000
Relationship: Director
Ownership: Direct
2023-11-15Sale
Owner: Weaver, Gregory L
Title: Former EVP, CFO, & Director
Shares: 50,000
Price/Share: $0.65
Value: $32,500.00
Shares Owned: 55
Relationship: Director,Officer
Ownership: Direct
2023-06-20Purchase
Owner: Weaver, Gregory L
Title: EVP & CFO
Shares: 50,000
Price/Share: $0.97
Value: $48,500.00
Shares Owned: 50,055
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
14.37%
Inst. Shares: 1,238,775
Shares Outstanding: 8,622,289
2025-12-31
16.91%
Inst. Shares: 1,456,032
Shares Outstanding: 8,611,321
2025-09-30
14.62%
Inst. Shares: 1,258,603
Shares Outstanding: 8,611,428
2025-06-30
16.30%
Inst. Shares: 1,403,357
Shares Outstanding: 8,611,362
2025-03-31
21.68%
Inst. Shares: 1,869,271
Shares Outstanding: 8,622,289

Research Faster.
Invest Smarter.

ATOSSA THERAPEUTICS, INC. (ATOS) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.